Table 1
Parameter | No. Of Cases (n = 43) | |
|---|---|---|
Universal Precaution Workshop (UPW) for HCP | Â | |
January 2008 -- December 2008 | 2 | |
January 2009 -- October 2009 | 9 | |
Enrolment of HCP for PEP at CoE | Â | |
October 2008 -- May 2009 | 19(44.18%) | |
June 2009 -- October 2009 | 24(55.81%) | |
HCP Category Enrolled for PEP at CoE | Â | |
Medics | 19(44.18%) | |
Paramedics | 21(48.8%) | |
Servants | 3(7%) | |
HIV Status of the HCP for PEP enrolment | Â | |
October 2008--May 2009(n = 19) | Reactive | 0 |
| Â | Non -- Reactive | 7(36.8%) |
| Â | Unknown | 12(63.15%) |
June 2009--October 2009(n = 24) | Reactive | 0 |
| Â | Non -- Reactive | 16(66.66%) |
| Â | Unknown | 3(12.5%) |
Type of Exposure | Â | |
Mild | 21(48.8%) | |
Moderate | 18(41.9%) | |
Severe | 4(9.3%) | |
Reporting Timeline of exposed HCP to the CoE | Â | |
<2 hours | 27(62.8%) | |
2 -- 24 hours | 9(20.9%) | |
24 -- 72 hours | 5(11.6%) | |
>72 hours | 2(4.7%) | |
HIV Status of the source | Â | |
Reactive | 22(51.2%) | |
Unknown | 21(48.8%) | |
PEP Regimen Prescribed | Â | |
Basic (Zidovudine+Lamivudine) | 30(69.76%) | |
Expanded (Zidovudine+Lamivudine+Lopinavir/Ritonavir) | 12(27.90%) | |
Expanded (Zidovudine+Lamivudine+Indinavir) | 1(2.32%) | |
HIV Status of exposed HCP post PEP at 6 months (n = 18) | Â | |
Reactive | 0 | |
Non -- Reactive | 3(16.66%) | |
Unknown | 15(83.33%) | |
HCP Not Completed 6 Months (n = 43) | 25(58.13%) | |